166 related articles for article (PubMed ID: 18210807)
1. [Imaging of brain acetylcholinesterase activity in dementias and extrapyramidal disorders].
Shinotoh H
Rinsho Shinkeigaku; 2007 Nov; 47(11):822-5. PubMed ID: 18210807
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
[TBL] [Abstract][Full Text] [Related]
3. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
4. [Introduction to and general remarks on molecular imaging].
Fukuda H; Okamura N
Brain Nerve; 2007 Mar; 59(3):203-7. PubMed ID: 17370645
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of simplified kinetic analyses for measurement of brain acetylcholinesterase activity using N-[11C]Methylpiperidin-4-yl propionate and positron emission tomography.
Sato K; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Aotsuka A; Ota T; Shiraishi T; Tanada S; Iyo M; Irie T
J Cereb Blood Flow Metab; 2004 Jun; 24(6):600-11. PubMed ID: 15181367
[TBL] [Abstract][Full Text] [Related]
6. Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease.
Bohnen NI; Kaufer DI; Hendrickson R; Ivanco LS; Lopresti B; Davis JG; Constantine G; Mathis CA; Moore RY; DeKosky ST
Neurosci Lett; 2005 May 20-27; 380(1-2):127-32. PubMed ID: 15854764
[TBL] [Abstract][Full Text] [Related]
7. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
[TBL] [Abstract][Full Text] [Related]
8. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
[TBL] [Abstract][Full Text] [Related]
9. Cerebral acetylcholinesterase imaging: development of the radioprobes.
Kikuchi T; Okamura T; Fukushi K; Takahashi K; Toyohara J; Okada M; Zhang MR; Irie T
Curr Top Med Chem; 2007; 7(18):1790-9. PubMed ID: 17979787
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.
Namba H; Fukushi K; Nagatsuka S; Iyo M; Shinotoh H; Tanada S; Irie T
Methods; 2002 Jul; 27(3):242-50. PubMed ID: 12183113
[TBL] [Abstract][Full Text] [Related]
11. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
Shimada H; Hirano S; Shinotoh H; Aotsuka A; Sato K; Tanaka N; Ota T; Asahina M; Fukushi K; Kuwabara S; Hattori T; Suhara T; Irie T
Neurology; 2009 Jul; 73(4):273-8. PubMed ID: 19474411
[TBL] [Abstract][Full Text] [Related]
12. [PET study of cholinergic system in the brain].
Shinotoh H
Rinsho Shinkeigaku; 1999 Jan; 39(1):33-5. PubMed ID: 10377794
[TBL] [Abstract][Full Text] [Related]
13. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
14. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.
Iyo M; Namba H; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
Lancet; 1997 Jun; 349(9068):1805-9. PubMed ID: 9269216
[TBL] [Abstract][Full Text] [Related]
15. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
16. Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease.
Eggers C; Herholz K; Kalbe E; Heiss WD
Neurosci Lett; 2006 Nov; 408(1):46-50. PubMed ID: 16996687
[TBL] [Abstract][Full Text] [Related]
17. [The other dementias: the neuropathology of the non-Alzheimer's disease dementias].
Hamilton RL
Rev Neurol; 2003 Jul 16-31; 37(2):130-9. PubMed ID: 12938072
[TBL] [Abstract][Full Text] [Related]
18. Rat brain acetylcholinesterase visualized with [11C]physostigmine.
Planas AM; Crouzel C; Hinnen F; Jobert A; Né F; DiGiamberardino L; Tavitian B
Neuroimage; 1994 Jun; 1(3):173-80. PubMed ID: 9343568
[TBL] [Abstract][Full Text] [Related]
19. What is 'early onset dementia'?
Miyoshi K
Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
